Related references
Note: Only part of the references are listed.Effects of Fusaric Acid Treatment on HEp2 and Docetaxel-Resistant HEp2 Laryngeal Squamous Cell Carcinoma
Jian Ye et al.
CHEMOTHERAPY (2013)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of fusaric acid and paclitaxel or carboplatin
Jeffrey R. Jaglowski et al.
CANCER LETTERS (2006)
The effect of single agent oral fusaric acid (FA) on the growth of subcutaneously xenografted SCC-1 cells in a nude mouse model
James M. Ruda et al.
INVESTIGATIONAL NEW DRUGS (2006)
Matrix effects: The Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry
PJ Taylor
CLINICAL BIOCHEMISTRY (2005)
Opinion - Profiling early head and neck cancer
KD Hunter et al.
NATURE REVIEWS CANCER (2005)
Fusaric acid: A novel agent and mechanism to treat HNSCC
BC Jr Stack et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2004)
Flavopiridol inhibits vascular endothelial growth factor production induced by hypoxia or picolinic acid in human neuroblastoma
A Rapella et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Share Paper
